Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1978 2
1985 1
2006 1
2008 1
2010 1
2017 3
2018 1
2019 3
2020 1
2021 2
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication.
Miles D, Ciruelos E, Schneeweiss A, Puglisi F, Peretz-Yablonski T, Campone M, Bondarenko I, Nowecki Z, Errihani H, Paluch-Shimon S, Wardley A, Merot JL, Trask P, du Toit Y, Pena-Murillo C, Revelant V, Klingbiel D, Bachelot T; PERUSE investigators. Miles D, et al. Ann Oncol. 2021 Oct;32(10):1245-1255. doi: 10.1016/j.annonc.2021.06.024. Epub 2021 Jul 2. Ann Oncol. 2021. PMID: 34224826 Free article. Clinical Trial.
ID1 Is Critical for Tumorigenesis and Regulates Chemoresistance in Glioblastoma.
Sachdeva R, Wu M, Smiljanic S, Kaskun O, Ghannad-Zadeh K, Celebre A, Isaev K, Morrissy AS, Guan J, Tong J, Chan J, Wilson TM, Al-Omaishi S, Munoz DG, Dirks PB, Moran MF, Taylor MD, Reimand J, Das S. Sachdeva R, et al. Among authors: smiljanic s. Cancer Res. 2019 Aug 15;79(16):4057-4071. doi: 10.1158/0008-5472.CAN-18-1357. Epub 2019 Jul 10. Cancer Res. 2019. PMID: 31292163
The Cost of Foodborne Illness and Its Sequelae in Australia Circa 2019.
Glass K, McLure A, Bourke S, Cribb DM, Kirk MD, March J, Daughtry B, Smiljanic S, Lancsar E. Glass K, et al. Among authors: smiljanic s. Foodborne Pathog Dis. 2023 Oct;20(10):419-426. doi: 10.1089/fpd.2023.0015. Epub 2023 Aug 22. Foodborne Pathog Dis. 2023. PMID: 37610847
Estimation of Cadmium uptake by tobacco plants from laboratory leaching tests.
Marković JP, Jović MD, Smičiklas ID, Šljivić-Ivanović MZ, Smiljanić SN, Onjia AE, Popović AR. Marković JP, et al. Among authors: smiljanic sn. J Environ Sci Health A Tox Hazard Subst Environ Eng. 2018 Mar 21;53(4):352-361. doi: 10.1080/10934529.2017.1401396. Epub 2017 Dec 27. J Environ Sci Health A Tox Hazard Subst Environ Eng. 2018. PMID: 29281501
[Hereditary nephritis (Alport)].
Popović-Rolović M, Smiljanić S. Popović-Rolović M, et al. Among authors: smiljanic s. Srp Arh Celok Lek. 1978 Apr;106(4):353-68. Srp Arh Celok Lek. 1978. PMID: 751225 Serbian. No abstract available.
Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE).
Bachelot T, Ciruelos E, Schneeweiss A, Puglisi F, Peretz-Yablonski T, Bondarenko I, Paluch-Shimon S, Wardley A, Merot JL, du Toit Y, Easton V, Lindegger N, Miles D; PERUSE investigators. Bachelot T, et al. Ann Oncol. 2019 May 1;30(5):766-773. doi: 10.1093/annonc/mdz061. Ann Oncol. 2019. PMID: 30796821 Free article. Clinical Trial.
17 results